Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Disorders of the Nervous System

Blood–Brain Barrier Disruption in Preclinical Mouse Models of Stroke Can Be an Experimental Artifact Caused by Craniectomy

Che-Wei Liu, Eric Yuhsiang Wang, Hwai-Lee Wang, Kate Hsiurong Liao, Hsiao-Yun Chen, Hank Szuhan Chen and Ted Weita Lai
eNeuro 12 October 2022, 9 (5) ENEURO.0343-22.2022; https://doi.org/10.1523/ENEURO.0343-22.2022
Che-Wei Liu
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan
2School of Medicine, China Medical University, Taichung 404333, Taiwan
3Department of Neurosurgery, Taipei Veterans General Hospital, Taipei 112201, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Yuhsiang Wang
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan
2School of Medicine, China Medical University, Taichung 404333, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hwai-Lee Wang
4Graduate Institute of Clinical Medical Science, China Medical University, Taichung 404333, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate Hsiurong Liao
4Graduate Institute of Clinical Medical Science, China Medical University, Taichung 404333, Taiwan
5Department of Anesthesiology, China Medical University Hospital, Taichung 404327, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kate Hsiurong Liao
Hsiao-Yun Chen
4Graduate Institute of Clinical Medical Science, China Medical University, Taichung 404333, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hank Szuhan Chen
2School of Medicine, China Medical University, Taichung 404333, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ted Weita Lai
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan
2School of Medicine, China Medical University, Taichung 404333, Taiwan
4Graduate Institute of Clinical Medical Science, China Medical University, Taichung 404333, Taiwan
6Drug Development Center, China Medical University, Taichung 404333, Taiwan
7Translational Medicine Research Center, China Medical University Hospital, Taichung 404327, Taiwan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    dMCAO unilaterally increased BBB permeability to EBD and fluorescein in mice. A1–C3, Focal cerebral ischemia of the right motor cortex was induced in mice, and the mice were intravenously injected with EBD (A1–A3), fluorescein (B1–B3), or 10 kDa dextran-FITC (C1–C3) at the indicated time points (C, control). Extravasation of the circulating tracers into the left (contralateral, nonischemic) hemisphere, right (ipsilateral, ischemic) hemisphere, and cerebellum was used as a measure of BBB permeability, and extravasation of the tracers into the liver and the concentrations of the tracers remaining in the blood were used as measures of tracer stability in the circulation. In A1–A3, n = 10 mice/time point except for the cerebellum, for which n = 5 mice/time point. In B1–B3, n = 5–7 mice/time point. In C1–C3, n = 5 mice/time point. The concentrations of tracers in the brain were compared by mixed-effects ANOVA (A1) or two-way repeated-measures ANOVA (matching brain regions from the same mouse; B1 and C1) followed by Holm–Sidak multiple-comparisons test. The concentrations of tracers in the liver (A2, B2, and C2) and blood (A3, B3, and C3) were compared with one-way ANOVA followed by Holm–Sidak multiple-comparisons test. *p < 0.05, ***p < 0.001, compared with the control. n.s., No significant difference.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Craniectomy in mice unilaterally increased BBB permeability to EBD and fluorescein. A1–C3, Mice were subjected to craniectomy above the right motor cortex and intravenously injected with EBD (A1–A3), fluorescein (B1–B3), or 10 kDa dextran-FITC (C1–C3) 24 h later. Extravasation of the circulating tracers into the left (contralateral) hemisphere, right (ipsilateral) hemisphere, and cerebellum was used as a measure of BBB permeability, and extravasation of the tracers into the liver and the concentrations of the tracers remaining in the blood were used as measures of tracer stability in the circulation. n = 8 mice/group for EBD (A1–A3) and n = 5 mice/time point for fluorescein (B1–B3) and 10 kDa dextran-FITC (C1–C3). The concentrations of tracers in the brain were compared by two-way repeated-measures ANOVA (matching brain regions from the same mouse) followed by Holm–Sidak multiple-comparisons test (A1, B1, and C1). The concentrations of tracers in the liver (A2, B2, and C2) and blood (A3, B3, and C3) were compared with unpaired t test. **p < 0.01, ***p < 0.001, compared with the control. n.s., No significant difference.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Craniectomy contributed to BBB disruption but not to cerebral infarction and neurodegeneration in a preclinical mouse model of stroke. A, Mice were subjected to focal cerebral ischemia induced by dMCAO or craniectomy above the right motor cortex and intravenously injected with EBD 24 h later. Extravasation of the circulating tracers into the left (contralateral, nonischemic) hemisphere and right (ipsilateral, ischemic) hemisphere was used as a measure of BBB permeability (n = 10 mice/group). The concentrations of tracers in the brain were compared by two-way repeated-measures ANOVA (matching brain regions from the same mouse) followed by Holm–Sidak multiple-comparisons test. *p < 0.05; ***p < 0.001, compared with the control or for dMCAO versus craniectomy. n.s., No significant difference. B, C, Mice were subjected to focal cerebral ischemia induced by dMCAO or craniectomy above the right motor cortex and killed 24 h later to prepare coronal brain sections, which were stained with TTC or Fluoro-Jade to identify infarcted brain regions (B) and assess neurodegeneration (C), respectively. Each image in B and C is representative of n = 3 mice/group; there were no noticeable differences between individual mice from the same group.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    dMCAO unilaterally increased cerebral extravasation of endogenous albumin in mice. A, Mice were subjected to focal cerebral ischemia of the right motor cortex and perfused to remove circulating albumin from the blood 3, 6, or 12 h later, and extravasation of albumin into the left (contralateral, nonischemic) and right (ipsilateral, ischemic) hemispheres was assessed by Western blotting. Control mice exhibited no cerebral ischemia. B, Summarized results for A. C, Mice were subjected to focal cerebral ischemia of the right motor cortex and perfused to remove circulating albumin from the blood 12, 24, 48, or 72 h later, and extravasation of albumin into the left (contralateral, nonischemic) and right (ipsilateral, ischemic) hemispheres was evaluated by Western blotting. D, Summarized result for C. In B and D, albumin extravasation was compared by two-way repeated-measures ANOVA (matching brain regions from the same mouse) followed by Holm–Sidak multiple-comparisons test. **p < 0.01, ***p < 0.001. n.s., No significant difference.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Craniectomy contributed to increased cerebral extravasation of endogenous albumin in a preclinical stroke model independent of dural tearing. A, Mice were subjected to craniectomy above the right motor cortex and perfused to remove circulating albumin from the blood 3 or 24 h later, and extravasation of albumin into the left (contralateral) and right (ipsilateral) hemispheres was assessed by Western blotting. B, Summarized result for A. C, Mice were subjected to focal cerebral ischemia induced by dMCAO to or craniectomy above the right motor cortex and perfused to remove circulating albumin from the blood 24 h later, and extravasation of albumin into the left (contralateral, nonischemic) and right (ipsilateral, ischemic) hemispheres was assessed by Western blotting. D, Summarized data for C. E, To determine the effect of dural tearing, rats were injected with Evans blue dye to facilitate identification of the dura mater during craniectomy and were perfused to remove circulating albumin from the blood 24 h later; and extravasation of albumin into the left (contralateral, nonischemic) and right (ipsilateral, ischemic) hemispheres was evaluated by Western blotting. F, Summarized data for E. In B, D, and F, albumin extravasation was compared by two-way repeated-measures ANOVA (matching brain regions from the same mouse) followed by Holm–Sidak multiple-comparisons test. *p < 0.05, **p < 0.01, ***p < 0.001. n.s., No significant difference.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    BBB disruption caused by craniectomy was region specific. A–F, Mice were subjected to craniectomy above the right motor cortex and perfused to remove circulating albumin from the blood 24 h later, and extravasation of albumin into the left (contralateral) and right (ipsilateral) prefrontal cortex (A, B), motor cortex (C, D), and striatum (E, F) was assessed by Western blotting. B, Summarized result for A. D, Summarized result for C. F, Summarized result for E. In B, D, and F, albumin extravasation was compared by two-way repeated-measures ANOVA (matching brain regions from the same mouse) followed by Holm–Sidak multiple-comparisons test. ***p < 0.001. n.s., no significant difference.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Craniectomy contributed to cerebral edema in a preclinical mouse model of stroke. Mice were subjected to focal cerebral ischemia induced by dMCAO or craniectomy above the right motor cortex and water (edema) contents of their brains were determined 24 h later. n = 6 mice/group. Cerebral edemas were compared by two-way repeated-measures ANOVA (matching brain regions from the same mouse) followed by Holm–Sidak multiple-comparisons test. **p < 0.01, ***p < 0.001, compared with the control group. n.s., No significant difference.

Back to top

In this issue

eneuro: 9 (5)
eNeuro
Vol. 9, Issue 5
September/October 2022
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Blood–Brain Barrier Disruption in Preclinical Mouse Models of Stroke Can Be an Experimental Artifact Caused by Craniectomy
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Blood–Brain Barrier Disruption in Preclinical Mouse Models of Stroke Can Be an Experimental Artifact Caused by Craniectomy
Che-Wei Liu, Eric Yuhsiang Wang, Hwai-Lee Wang, Kate Hsiurong Liao, Hsiao-Yun Chen, Hank Szuhan Chen, Ted Weita Lai
eNeuro 12 October 2022, 9 (5) ENEURO.0343-22.2022; DOI: 10.1523/ENEURO.0343-22.2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Blood–Brain Barrier Disruption in Preclinical Mouse Models of Stroke Can Be an Experimental Artifact Caused by Craniectomy
Che-Wei Liu, Eric Yuhsiang Wang, Hwai-Lee Wang, Kate Hsiurong Liao, Hsiao-Yun Chen, Hank Szuhan Chen, Ted Weita Lai
eNeuro 12 October 2022, 9 (5) ENEURO.0343-22.2022; DOI: 10.1523/ENEURO.0343-22.2022
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • blood–brain barrier
  • cerebral edema
  • dMCAO
  • mice
  • preclinical model
  • stroke

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Parallel gene expression changes in ventral midbrain dopamine and GABA neurons during normal aging
  • Lactate receptor HCAR1 affects axonal development and contributes to lactate’s protection of axons and myelin in experimental neonatal hypoglycemia
  • Demyelination produces a shift in the population of cortical neurons that synapse with callosal oligodendrocyte progenitor cells
Show more Research Article: New Research

Disorders of the Nervous System

  • Expression of HDAC3-Y298H Point Mutant in Medial Habenula Cholinergic Neurons Has No Effect on Cocaine-Induced Behaviors
  • Parallel gene expression changes in ventral midbrain dopamine and GABA neurons during normal aging
  • Demyelination produces a shift in the population of cortical neurons that synapse with callosal oligodendrocyte progenitor cells
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.